Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
118 studies found for:    "hereditary hypophosphatemic rickets" OR "Rickets"
Show Display Options
RSS Create an RSS feed from your search for:
"hereditary hypophosphatemic rickets" OR "Rickets"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Enrolling by invitation Calcimimetics in Hypophosphatemic Rickets
Condition: Familial Hypophosphatemic Rickets
Intervention: Drug: Cinacalcet
2 Recruiting Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.
Condition: Autosomal Dominant Hypophosphatemic Rickets
Intervention: Dietary Supplement: Iron
3 Unknown  Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets
Condition: Hypophosphatemic Rickets, X-Linked Dominant
Intervention: Drug: Cinacalcet
4 Completed Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets
Condition: Primary Hypophosphatemic Rickets
Intervention: Drug: Z-521
5 Completed A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia
Condition: X-linked Hypophosphatemic Rickets/Osteomalacia
Intervention: Drug: KRN23
6 Completed Growth Hormone Treatment in Children With Hypophosphatemic Rickets
Condition: X Linked Hypophosphatemic Rickets
Intervention: Drug: norditropine simplex
7 Unknown  Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic Rickets
Conditions: Hypophosphatemic Rickets;   Growth Disorders;   Somatropin Therapy
Intervention: Drug: somatropin
8 Completed Calcitonin for Treating X-linked Hypophosphatemia
Condition: Hypophosphatemic Rickets, X Linked Dominant
Interventions: Drug: nasal salmon calcitonin;   Drug: Saline Nasal Spray Placebo
9 Completed Study to Assess the Use of a Simple Lab Test to Screen for Rickets in Children
Condition: Rickets
Intervention:
10 Completed Role of Calcium And Vitamin D In Nutritional Rickets And It's Management
Condition: Nutritional Rickets
Interventions: Drug: Vitamin D;   Drug: Calcium Carbonate;   Drug: Vitamin D and Calcium
11 Completed Vitamin D and Genetics in Nutritional Rickets
Condition: Nutritional Rickets
Interventions: Dietary Supplement: Vitamin D + Calcium;   Dietary Supplement: Calcium;   Dietary Supplement: Vitamin D2;   Dietary Supplement: Vitamin D3
12 Active, not recruiting Hypophosphatemic Rickets in Norway
Conditions: Hypophosphatemia, Familial;   Rickets;   Hyperphosphatemia
Interventions: Dietary Supplement: Alfacalcidol; phosphate.;   Drug: Sevelamer
13 Completed A Study of KRN23 in X-linked Hypophosphatemia
Condition: X-linked Hypophosphatemia
Interventions: Drug: Placebo;   Drug: KRN23
14 Completed A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
Condition: X-linked Hypophosphatemia
Intervention: Drug: KRN23
15 Completed An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
Condition: X-linked Hypophosphatemia
Intervention: Drug: KRN23
16 Enrolling by invitation Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)
Condition: X-Linked Hypophosphatemia
Intervention: Drug: KRN23
17 Active, not recruiting Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH)
Condition: X-linked Hypophosphatemia
Interventions: Biological: KRN23;   Other: Placebo
18 Active, not recruiting Study of KRN23, a Recombinant Fully Human Monoclonal Antibody Against FGF23, in Pediatric Subjects With X-linked Hypophosphatemia (XLH)
Condition: X-linked Hypophosphatemia
Intervention: Drug: KRN23
19 Active, not recruiting Study of the Safety, Pharmacodynamics and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)
Condition: X-Linked Hypophosphatemia
Intervention: Drug: KRN23
20 Recruiting Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)
Condition: X-Linked Hypophosphatemia
Interventions: Biological: KRN23;   Drug: Oral Phosphate;   Drug: Active Vitamin D

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.